Implementation of patient education at first and second dispensing of statins in Dutch community pharmacies: The sequel of a cluster randomized trial

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Van De Steeg Van Gompel, Caroline H P A ^a   Wensing, Michel ^a   De Smet, Peter A G M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Scientific Institute Dutch Pharmacists   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; CHECKLIST; CLINICAL COMPETENCE; CLINICAL TRIAL; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; EVIDENCE BASED MEDICINE; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; METHODOLOGY; NETHERLANDS; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST; PHARMACY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; STANDARD; STATISTICAL MODEL; STATISTICS; TIME; UTILIZATION REVIEW;

CARDIOVASCULAR DISEASES; CHECKLIST; CLINICAL COMPETENCE; CLUSTER ANALYSIS; COMMUNITY PHARMACY SERVICES; COUNSELING; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PLAN IMPLEMENTATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; NETHERLANDS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHARMACIES; PHARMACISTS' AIDES; PROGRAM EVALUATION; TIME FACTORS;

EID: 81055127606     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-313     Document Type: Article

References (26)

1. Implementation of a pharmacist-led intervention to enhance statin prescribing for secondary prevention in primary care: a cluster randomized trial. van de Steeg-van Gompel CH, Wensing M, De Smet PA, Eur J Cardiovasc Prev Rehabil 2011
2. Nederlandse Apotheek Norm (NAN) 2006. Richtlijn 2: Farmaceutische zorg- en dienstverlening. KNMP, http://www.knmp.nl/organisatie-regelgeving/normen-en- richtlijnen/normen/nederlandse-apotheek-norm-nan Last accessed: June 28 2011
3. A review of counseling practices on prescription medicines in community pharmacies. Puspitasari HP, Aslani P, Krass I, Res Social Adm Pharm 2009 5 197 210 10.1016/j.sapharm.2008.08.006 19733821
4. Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Liberopoulos EN, Florentin M, Mikhailidis DP, Elisaf MS, Expert Opin Drug Saf 2008 7 717 725 10.1517/14740330802396984 18983218
5. Non-adherence to statin therapy: a major challenge for preventive cardiology. Bates TR, Connaughton VM, Watts GF, Expert Opin Pharmacother 2009 10 2973 2985 10.1517/14656560903376186 19954271
6. Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. Perreault S, Blais L, Lamarre D, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J, Br J Clin Pharmacol 2005 59 564 573 10.1111/j.1365-2125.2005.02355.x 15842555 (Pubitemid 40632247)
7. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM, Can J Cardiol 2005 21 485 488 15917876 (Pubitemid 40823600)
8. Persistence of combination of evidence-based medical therapy in patients with acute coronary syndromes. Amar J, Ferrières J, Cambou JP, Amelineau E, Danchin N, Arch Cardiovasc Dis 2008 101 301 306 10.1016/j.acvd.2008.04.005 18656088
9. Persistent Use of Secondary Preventive Drugs Declines Rapidly During the First 2 Years After Stroke. Glader EL, Sjolander M, Eriksson M, Lundberg M, Stroke 2010 41 397 401 10.1161/STROKEAHA.109.566950 20075360
10. Long-term Medication Adherence after Myocardial Infarction: Experience of a Community. Shah ND, Dunlay SM, Ting HH, Montori VM, Thomas RJ, Wagie AE, Roger VL, Am J Med 2009 122 961 19786163
11. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: A retrospective analysis. van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A, Clin Ther 2005 27 1806 1814 10.1016/j.clinthera.2005.11.003 16368451 (Pubitemid 41815231)
12. Implementation of a discontinuation letter to reduce long-term benzodiazepine use - A cluster randomized trial. van de Steeg-van Gompel C, Wensing M, De Smet PAGM, Drug Alcohol Depend 2009 99 105 114 10.1016/j.drugalcdep.2008.07.009 18801626
13. Community pharmacy and patient-oriented activities: the Dutch case. Pronk M, Blom L, Jonkers R, Bakker A, Patient Educ Couns 2002 46 39 45 10.1016/S0738-3991(01)00148-3 11804768 (Pubitemid 34136107)
14. The diffusion process of patient education in Dutch community pharmacy: an exploration. Pronk MC, Blom AT, Jonkers R, Van BA, Patient Educ Couns 2001 42 115 121 10.1016/S0738-3991(00)00091-4 11118777
15. From best evidence to best practice: effective implementation of change in patients' care. Grol R, Grimshaw J, Lancet 2003 362 1225 1230 10.1016/S0140-6736(03)14546-1 14568747 (Pubitemid 37255352)
16. Tailoring quality improvement interventions to identified barriers: a multiple case analysis. Bosch M, van der WT, Wensing M, Grol R, J Eval Clin Pract 2007 13 161 168 10.1111/j.1365-2753.2006.00660.x 17378860 (Pubitemid 46449789)
17. Effective implementation: a model. Grol R, Wensing M, Improving Patient Care. The Implementation of Change in Clinical Practice London, Elsevier Butterworth Heinemann, Grol R, Wensing M, Eccles M, 2005 41 57
18. Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Heritier SR, Gebski VJ, Keech AC, Med J Aust 2003 179 438 440 14558871 (Pubitemid 37328013)
19. Pharmacists in primary care. Determinants of the care-providing function of Dutch community pharmacists in primary care. Muijrers PE, Knottnerus JA, Sijbrandij J, Janknegt R, Grol RP, Pharm World Sci 2004 26 256 262 15598065 (Pubitemid 39287309)
20. Psychological determinants of the intention to educate patients about benzodiazepines. Ten Wolde G, Dijkstra A, Van Empelen P, Knuistingh Neven A, Zitman F, Pharm World Sci 2008 30 336 342 10.1007/s11096-007-9183-2 18095183
21. Interventions for enhancing medication adherence. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X, Cochrane Database Syst Rev 2008 D000011
22. The Statin Choice decision aid in primary care: A randomized trial. Mann DM, Ponieman D, Montori VM, Arciniega J, McGinn T, Patient Educ Couns 2010 80 138 140 10.1016/j.pec.2009.10.008 19959322
23. The evaluation of an intervention based on the application of patient self-completion concordance forms in Dutch community pharmacies and the effect on adherence to chronic medication. Geurts MME, Pot JLW, Schepers EH, Tromp C, Colijn CG, Dijkstra A, de Gier JJ, Patient Educ Couns 2010 78 85 90 10.1016/j.pec.2009.04.005 19443169
24. Improving the physician-patient cardiovascular risk dialogue to improve statin adherence. Casebeer L, Huber C, Bennett N, Shillman R, Abdolrasulnia M, Salinas G, Zhang S, BMC Fam Pract 2009 10 48 10.1186/1471-2296-10-48 19566950
25. The COACH Program Produces Sustained Improvements in Cardiovascular Risk Factors and Adherence to Recommended Medications - Two Years Follow-up. Jelinek M, Vale MJ, Liew D, Grigg L, Dart A, Hare DL, Best JD, Heart Lung Circ 2009 18 388 392 10.1016/j.hlc.2009.06.001 19648058
26. Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin. Willich SN, Englert H, Sonntag F, Voller H, Meyer-Sabellek W, Wegscheider K, Windler E, Katus H, Muller-Nordhorn J, Eur J Cardiovasc Prev Rehabil 2009 16 180 187 10.1097/HJR.0b013e3283262ac3 19174696